Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
C. Marugan, B. Ortigosa, N. Sanz-Gomez…·G. de Carcer
The paper identifies TPX2 as a gene that increases breast cancer sensitivity to dasatinib by activating the YAP pathway, and shows TPX2 and YAP are biomarkers for poor prognosis and potential dasatinib therapy.
M. Gamez-Chiachio, A. Molina-Crespo, C. Ramos-Nebot…·G. Moreno-Bueno
This study identifies GSDMB over-expression as a driver of HER2-targeted therapy resistance through autophagy induction and shows that combining lapatinib with chloroquine enhances therapeutic efficacy in GSDMB-positive tumors.
D. SARRIO, A. ROJO-SEBASTIAN, A. TEIJO…·G. MORENO-BUENO
This study uses novel knock-in mouse models to investigate GSDMB2's role in cancer, finding it does not significantly drive tumorigenesis but may reduce gastric carcinogenesis.
A. Jimenez-Segovia, A. Mota, A. Rojo-Sebastian…·K. Stamatakis
This paper identifies PGF2α-induced TGFβ-PMEPA1 pathway as a driver of epithelial plasticity and ovarian cancer progression, with PMEPA1 as a therapeutic target and prognostic biomarker.
M. I. Calvo Sanchez, E. Carrasco, S. Fernandez-Martos…·J. Espada
This study identifies Endoglin as a key component in the molecular oscillator regulating hair follicle cycles by mediating feedback crosstalk between Wnt/β-catenin and Bmp/Smad signals.